FGFR4 and hyperphosphatemia: Mice expressing constitutively active FGFR4 developed cardiac remodeling despite normal serum phosphate levels, whereas global and cardiac-specific FGFR4 knockout mice were protected from cardiac remodeling despite CKD-associated hyperphosphatemia.